Amgen Inc. (BIT:1AMGN)
Italy flag Italy · Delayed Price · Currency is EUR
306.53
-0.99 (-0.32%)
At close: Feb 11, 2026

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 166.37 billion. The enterprise value is 204.69 billion.

Market Cap166.37B
Enterprise Value 204.69B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date Feb 3, 2026
Ex-Dividend Date Nov 20, 2025

Share Statistics

Current Share Class 538.48M
Shares Outstanding n/a
Shares Change (YoY) +0.19%
Shares Change (QoQ) +0.18%
Owned by Insiders (%) 0.15%
Owned by Institutions (%) 80.94%
Float 537.10M

Valuation Ratios

The trailing PE ratio is 25.33 and the forward PE ratio is 16.34.

PE Ratio 25.33
Forward PE 16.34
PS Ratio 5.32
PB Ratio 22.56
P/TBV Ratio n/a
P/FCF Ratio 24.12
P/OCF Ratio 19.62
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.23, with an EV/FCF ratio of 29.67.

EV / Earnings 31.17
EV / Sales 6.61
EV / EBITDA 14.23
EV / EBIT 20.41
EV / FCF 29.67

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.31.

Current Ratio 1.14
Quick Ratio 0.73
Debt / Equity 6.31
Debt / EBITDA 3.20
Debt / FCF 6.74
Interest Coverage 4.32

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.77%.

Return on Equity (ROE) 106.10%
Return on Assets (ROA) 8.15%
Return on Invested Capital (ROIC) 18.77%
Return on Capital Employed (ROCE) 18.28%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 1.12M
Profits Per Employee 234,552
Employee Count28,000
Asset Turnover 0.40
Inventory Turnover 1.62

Taxes

In the past 12 months, Amgen has paid 1.08 billion in taxes.

Income Tax 1.08B
Effective Tax Rate 14.09%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 287.24
200-Day Moving Average 261.43
Relative Strength Index (RSI) 63.04
Average Volume (20 Days) 54

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.48

Income Statement

In the last 12 months, Amgen had revenue of EUR 31.30 billion and earned 6.57 billion in profits. Earnings per share was 12.12.

Revenue31.30B
Gross Profit 22.16B
Operating Income 10.13B
Pretax Income 7.64B
Net Income 6.57B
EBITDA 14.53B
EBIT 10.13B
Earnings Per Share (EPS) 12.12
Full Income Statement

Balance Sheet

The company has 7.78 billion in cash and 46.51 billion in debt, with a net cash position of -38.73 billion.

Cash & Cash Equivalents 7.78B
Total Debt 46.51B
Net Cash -38.73B
Net Cash Per Share n/a
Equity (Book Value) 7.37B
Book Value Per Share 13.68
Working Capital 3.04B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.48 billion and capital expenditures -1.58 billion, giving a free cash flow of 6.90 billion.

Operating Cash Flow 8.48B
Capital Expenditures -1.58B
Free Cash Flow 6.90B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 70.78%, with operating and profit margins of 32.37% and 20.98%.

Gross Margin 70.78%
Operating Margin 32.37%
Pretax Margin 24.42%
Profit Margin 20.98%
EBITDA Margin 46.43%
EBIT Margin 32.37%
FCF Margin 22.04%

Dividends & Yields

This stock pays an annual dividend of 6.23, which amounts to a dividend yield of 2.01%.

Dividend Per Share 6.23
Dividend Yield 2.01%
Dividend Growth (YoY) -25.34%
Years of Dividend Growth n/a
Payout Ratio 66.14%
Buyback Yield -0.19%
Shareholder Yield 1.83%
Earnings Yield 3.95%
FCF Yield 4.15%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7